期刊文献+

CT灌注成像在乳腺良、恶性病变诊断中的应用 被引量:44

CT perfusion : the clinical application in the diagnosis of breast diseases
原文传递
导出
摘要 目的对乳腺病变CT灌注进行初步评价。方法22例乳腺疾病女性行乳腺CT灌注。其中纤维腺瘤1例(合并乳腺囊肿);其他良性病变5例;乳腺癌16例。采用电影模式(0.5s/r),120kV,60mA,5mm×4;注射流率4.0ml/s,延迟5s,扫描时间50s。利用GE公司Perfusion3体部灌注软件,分别测量血流量(BF)、血容量(BV)、平均通过时间(MTT)和表面通透性(PS),并进行统计学分析。结果乳腺癌组BF、BV、MTT、PS均值分别为(33.55±28.40)ml.min-1.100g-1、(5.60±3.08)ml/100g、(15.37±6.41)s和(18.71±10.42)ml.min-1.100g-1,对侧正常乳腺组BF、BV、MTT、PS均值分别为(10.36±9.44)ml.min-1.100g-1、(0.70±0.22)ml/100g、(13.55±7.27)s和(1.54±1.74)ml.min-1.100g-1,2组间BF、BV、PS均值差异有统计学意义(P<0.05),MTT均值差异无统计学意义(P>0.05)。纤维腺瘤BF、BV、MTT、PS均值分别为(62.57±19.62)ml.min-1.100g-1、(7.37±1.30)ml/100g、(11.24±3.34)s和(27.63±3.87)ml.min-1.100g-1,与乳腺癌组之间PS均值差异有统计学意义(P<0.05),BF、BV、MTT均值差异无统计学意义(P>0.05)。其他良性病变BF、BV、MTT、PS均值分别为(7.65±10.24)ml.min-1.100g-1、(1.23±0.97)ml/100g、(14.94±10.68)s和(1.81±1.72)ml.min-1.100g-1,与乳腺癌组之间BF、BV、PS均值差异有统计学意义(P<0.05),MTT均值差异无统计学意义(P>0.05)。结论CT灌注成像能反映乳腺病变的血液灌注特点,提供有价值的血流动力学信息,有助于乳腺良、恶性病变的鉴别诊断。 Objective To assess the CT perfusion characteristics of breast diseases. Methods Twenty-two patients with fibroadenoma accompanied with cyst ( n = 1 ) , other benign diseases ( n = 5 ) , and carcinomas (n = 16) underwent breast CT scan. CT perfusion was performed for breast with cine mode (0. 5 s .per rotation ) on a muhislice CT scanner ,120 kV, 60 mA, 4 ×5 mm collimation. Contrast injection was done by using 50 ml nonionic contrast agent ( 300 mg L/ml ) , at a flow rate of 4 ml/s with a power injector, 5 seconds delay, and data acquisition lasted for 50 seconds. These data were processed on a GE AW 4. 1 workstation using perfusion 3 software package, and the mean BF, BV, MTF and PS were measured and statistically analyzed. Results The mean BF, BV, MTF and PS in carcinoma were (33.55 ± 28.40) ml·min^-1 · 100g^-1, (5.60±3.08) ml/100 g, (15.37 ±6.41) s, (18.71 ±10.42) ml · min^-1· 100 g^-1. The mean BF, BV, MTF and PS in contralateral normal breast of carcinoma were ( 10. 36 ± 9.44) ml· min^-1· 100g^-1, (0.70±0.22) ml/100 g, (13.55±7.27) s, (1.54±1.74) ml· min^-1 · 100 g^-1. The mean BF, BV, and PS between carcinoma and normal breast were statistically significant ( P 〈 0. 05 ) , and the mean MTF was not statistically significant ( P 〉 0. 05 ). The mean BF, BV, MTF and PSinfibroadenomawere (62. 57 ±19.62) ml · min^-1· 100 g^-1, (7.37 ±1.30) ml/100 g, (11.24± 3.34) s, (27. 63 ±3.87) ml · min^-1· 100 g^-1. The mean PS between carcinoma and fibroadenoma was statistically significant ( P 〈 0. 05 ) , and the mean BF, BV, and MTF were not statistically significant ( P 〉 0. 05). The mean BF, BV, MTF and PS in benign lesion were (7.65 ± 10. 24) ml · min^-1 · 100 g^-1, (1.23±0.97) ml/100g, (14.94±10.68) s, (1.81±1.72) ml· min^-1· 100g^-1. The meanBF, BV, and PS between carcinoma and benign lesion were statistically significant ( P 〈 0. 05 ) , and the mean MTT was not statistically significant ( P 〉 0. 05 ). Conclusion MSCT perfusion may reflect the features of breast diseases, and provide valuable hemodynamic message. These parameters have a value in diagnosis of breast diseases and are helpful for differential diagnosis.
出处 《中华放射学杂志》 CAS CSCD 北大核心 2005年第10期1050-1054,共5页 Chinese Journal of Radiology
  • 相关文献

参考文献14

  • 1Miles KA. Measurement of tissue perfusion by dynamic computed tomography. Br J Radiol, 1991, 64: 409-412.
  • 2Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology, 1993, 188: 405- 411.
  • 3Miles KA, Hayball MP, Dixon AK. Measurement of human pancreatic perfusion using dynamic computed tomography with perfusion imaging. Br J Radiol, 1995, 68: 471-475.
  • 4Koenig M, Klotz E, Luka B, et al. Perfusion CT of the brain: diagnostic approach for early detection of ischemic stroke. Radiology, 1998, 209: 85-93.
  • 5赵心明,周纯武,吴宁,罗德红,黄遥,王建卫,孙伟,梁颖.胰腺多层螺旋CT灌注研究[J].中华放射学杂志,2003,37(9):845-849. 被引量:90
  • 6Gandhi D, Hoeffner EG, Carlos RC, et al. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. initial results. J Comp Assist Tomogr, 2003, 27: 687-693.
  • 7Van Dijko CF, Brasch RC, Roberts TP, et al. Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology, 1996, 198: 813-818.
  • 8Mankoff DA, Dunnwakd LK, Gralow JR, et al. Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med, 2003, 44: 1806-1814.
  • 9Swensen SJ, Viggiano RW, Midthum DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology, 2000, 214: 73-80.
  • 10Hermans R, Meijerink M, Bogaert WV, et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys, 2003, 57: 1351-1356.

二级参考文献21

  • 1Petrella JR, Provenzale JM. MR perfusion imaging of the brain: techniques and applications. AJR, 2000, 175: 207-219.
  • 2Cha S, Lu S, Johnson G, et al. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging, 2000, 11: 114-119.
  • 3Aksoy FG, Lev MH. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical application. Semin Ultrasound CT MR, 2000, 21: 462-477.
  • 4Abdulrauf SI, Edvardsen K, Ho KL, et al. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytomas. J Neurosurg, 1998, 88: 513-520.
  • 5Leon SP, Folkerth RD, Black PM, et al. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer, 1996, 77: 362-372.
  • 6Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histopathologic findings. Radiology, 1994, 191: 41-51.
  • 7Aronen HJ, Glass J, Pardo FS, et al. Echo-planar MR cerebral blood volume mapping of gliomas. Acta Radiol, 1995, 36: 520-528.
  • 8Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR, 1998, 171: 1479-86.
  • 9Maxwell M, Naber SP, Wolfe HJ, et al. Expression of angiogenic growth factor genes in primary human astrocytomas may contribute to their growth and progression. Cancer Res, 1991, 51: 1345-1351.
  • 10Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T*2-weighted MR imaging. Neuroradiology, 1999, 211: 791-798.

共引文献121

同被引文献437

引证文献44

二级引证文献206

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部